Patents by Inventor Dustin Robert Britton

Dustin Robert Britton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutics and point of care lateral-flow test for virus and antibodies using tagged assembled proteins
    Patent number: 11892449
    Abstract: Provided is a multivalent protein that targets interaction of SARS-CoV-2 spike receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2) receptor protein. The multivalent proteins may also be used to treat subjects having cancer and/or a disease and/or viral infection. Also presented is a multiplex lateral flow test strips for simultaneous detection of the virus and viral antibodies.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 6, 2024
    Assignee: New York University
    Inventors: Jin Kim Montclare, Farbod Mahmoudinobar, Kamia Punia, Dustin Robert Britton
  • THERAPEUTICS AND POINT OF CARE LATERAL-FLOW TEST FOR VIRUS AND ANTIBODIES USING TAGGED ASSEMBLED PROTEINS
    Publication number: 20230280343
    Abstract: Provided is a multivalent protein that targets interaction of SARS-CoV-2 spike receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2) receptor protein. The multivalent proteins may also be used to treat subjects having cancer and/or a disease and/or viral infection. Also presented is a multiplex lateral flow test strips for simultaneous detection of the virus and viral antibodies.
    Type: Application
    Filed: November 23, 2022
    Publication date: September 7, 2023
    Inventors: Jin Kim Montclare, Farbod Mahmoudinobar, Kamia Punia, Dustin Robert Britton